Insider · CIK 0001286811

BALEZENTIS CARL W

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001286811

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-12-15	ENZO BIOCHEM INCS Sale	Pres., Enzo Life Sciences	SSale	−12.7K sh	$5.12	−$65.1K	25,950
2010-04-07	ENZO BIOCHEM INCS Sale	Pres., Enzo Life Sciences	SSale	−30 sh	$6.23	−$186.9	35,724
2010-01-29	ENZO BIOCHEM INCA Award	Pres., Enzo Life Sciences	AAward	+12K sh	—	—	35,754
2009-01-22	ENZO BIOCHEM INCA Award	Pres., Enzo Life Sciences	AAward	+10K sh	—	—	22,696
2008-10-30	ENZO BIOCHEM INCS Sale	Pres., Enzo Life Sciences	SSale	−580 sh	$5.35	−$3,103	4,650
2005-01-07	GENAISSANCE PHARMACEUTICALS INCA Award	Sr. V.P & President, Lark	AAward	+20K sh	$0.00	+$20	20,000
2005-01-07	GENAISSANCE PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Sr. V.P & President, Lark	AAward	+60K sh	$2.20	+$132K	60,000
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock Option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+63.4K sh	—	—	63,350
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock Option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+109K sh	—	—	108,600
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock Option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+58.2K sh	—	—	58,186
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock Option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+31.7K sh	—	—	31,675
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock Option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+31.7K sh	—	—	31,675
2004-04-01	LARK TECHNOLOGIES INCStock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	+17.5K sh	—	—	0
2004-04-01	LARK TECHNOLOGIES INCStock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	+17.5K sh	—	—	0
2004-04-01	LARK TECHNOLOGIES INCStock Option (right to buyD Disposition to Issuer	Director, President	DDisposition to Issuer	+35K sh	—	—	0
2004-04-01	LARK TECHNOLOGIES INCStock Option (right to buyD Disposition to Issuer	Director, President	DDisposition to Issuer	+60K sh	—	—	0
2004-04-01	LARK TECHNOLOGIES INCStock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	+32.1K sh	—	—	0
2004-04-01	GENAISSANCE PHARMACEUTICALS INCStock option (right to buy)A Award	Sr. V.P & President, Lark	AAward	+100K sh	$3.49	+$349K	100,000

Recent filings

Accepted (ET)
Dec 204
BALEZENTIS CARL W0000930413-10-006141
SEC(opens sec.gov)
Jul 24
BALEZENTIS CARL W0000930413-10-003794
SEC(opens sec.gov)
Feb 24
BALEZENTIS CARL W0000930413-10-000585
SEC(opens sec.gov)
Jan 264
ENZO BIOCHEM INC0000930413-09-000462
SEC(opens sec.gov)
Nov 34
ENZO BIOCHEM INC0000930413-08-006329
SEC(opens sec.gov)
Jan 214
BALEZENTIS CARL W0001179110-05-001485
SEC(opens sec.gov)
Apr 294
BALEZENTIS CARL W0001179110-04-009133
SEC(opens sec.gov)
Apr 294
BALEZENTIS CARL W0001179110-04-009131
SEC(opens sec.gov)

Companies

Address

C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE

NEW YORK, NY, 10003